Close
  Indian J Med Microbiol
 

Figure 6: The migration rate of the fraction on diabetic human dermal fibroblast cells. The various concentrations (12.5, 25, and 50 μg/mL) of Moringa oleifera leaf ethyl acetate fraction were treated on a wound created in diabetic human dermal fibroblast observed by scratch assay. Human dermal fibroblast-diabetic cells were scratched with p200 pipette tips, and photos were captured at 0 h. After the treatment with various concentrations of Moringa oleifera leaf ethyl acetate fraction, the cells were photographed after 24 h incubation (a) Control, (b) Moringa oleifera leaf ethyl acetate fraction 12.5 μg/mL, (c) Moringa oleifera leaf ethyl acetate fraction 25 μg/mL, (d) Moringa oleifera leaf ethyl acetate fraction 50 μg/mL, (e) allantoin 50 μg/mL

Figure 6: The migration rate of the fraction on diabetic human dermal fibroblast cells. The various concentrations (12.5, 25, and 50 μg/mL) of <i>Moringa oleifera</i> leaf ethyl acetate fraction were treated on a wound created in diabetic human dermal fibroblast observed by scratch assay. Human dermal fibroblast-diabetic cells were scratched with p200 pipette tips, and photos were captured at 0 h. After the treatment with various concentrations of <i>Moringa oleifera</i> leaf ethyl acetate fraction, the cells were photographed after 24 h incubation (a) Control, (b) <i>Moringa oleifera</i> leaf ethyl acetate fraction 12.5 μg/mL, (c) <i>Moringa oleifera</i> leaf ethyl acetate fraction 25 μg/mL, (d) <i>Moringa oleifera</i> leaf ethyl acetate fraction 50 μg/mL, (e) allantoin 50 μg/mL